Exelixis, Inc. (EXEL)
56.51
-0.59
(-1.03%)
USD |
NASDAQ |
Jul 10, 16:00
56.51
0.00 (0.00%)
After-Hours: 19:05
Exelixis Total Return Level : 57.10 for July 9, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| July 09, 2026 | 57.10 |
| July 08, 2026 | 56.11 |
| July 07, 2026 | 57.08 |
| July 06, 2026 | 55.53 |
| July 02, 2026 | 55.85 |
| July 01, 2026 | 53.96 |
| June 30, 2026 | 54.41 |
| June 29, 2026 | 54.28 |
| June 26, 2026 | 54.77 |
| June 25, 2026 | 53.23 |
| June 24, 2026 | 52.87 |
| June 23, 2026 | 51.34 |
| June 22, 2026 | 51.35 |
| June 18, 2026 | 51.91 |
| June 17, 2026 | 52.44 |
| June 16, 2026 | 52.10 |
| June 15, 2026 | 53.00 |
| June 12, 2026 | 53.13 |
| June 11, 2026 | 53.50 |
| June 10, 2026 | 52.58 |
| June 09, 2026 | 52.99 |
| June 08, 2026 | 51.74 |
| June 05, 2026 | 52.70 |
| June 04, 2026 | 52.49 |
| June 03, 2026 | 51.60 |
| Date | Value |
|---|---|
| June 02, 2026 | 48.54 |
| June 01, 2026 | 50.28 |
| May 29, 2026 | 50.48 |
| May 28, 2026 | 51.45 |
| May 27, 2026 | 50.03 |
| May 26, 2026 | 49.98 |
| May 22, 2026 | 50.15 |
| May 21, 2026 | 49.65 |
| May 20, 2026 | 49.90 |
| May 19, 2026 | 48.67 |
| May 18, 2026 | 49.84 |
| May 15, 2026 | 50.13 |
| May 14, 2026 | 51.10 |
| May 13, 2026 | 51.29 |
| May 12, 2026 | 49.46 |
| May 11, 2026 | 49.71 |
| May 08, 2026 | 48.16 |
| May 07, 2026 | 46.21 |
| May 06, 2026 | 48.70 |
| May 05, 2026 | 44.42 |
| May 04, 2026 | 44.17 |
| May 01, 2026 | 43.68 |
| April 30, 2026 | 44.46 |
| April 29, 2026 | 44.69 |
| April 28, 2026 | 44.93 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Merck & Co., Inc. | 384.49 |
| Catalyst Pharmaceuticals, Inc. | 31.47 |
| AbbVie, Inc. | 427.44 |
| Krystal Biotech, Inc. | 371.24 |
| Madrigal Pharmaceuticals, Inc. | 560.01 |